|
|
Description:
|
European Union (EU) Individual Case Safety Report (ICSR) message type
|
|
Information:
|
This message type is used in the submission of ICSR and Suspected Unexpected Serious Adverse Reactions (SUSARs) using ISO 27953-2:2011.
|
|
First Registration Authority
|
|
|
|
|
Address:
|
European Medicines Agency
30 Churchill Place, Canary Wharf, London E14 5EU
United Kingdom (the)
|
|
|
Creation date:
|
25 June 2014
|
|
Disclaimer: The owner of this site does not warrant or assume any liability or responsibility for the accuracy, completeness, or usefulness of any information available on this page (for more information, please read the complete disclaimer).
All rights reserved, Orange © 2024 |